Matches in SemOpenAlex for { <https://semopenalex.org/work/W3113156128> ?p ?o ?g. }
- W3113156128 endingPage "3828" @default.
- W3113156128 startingPage "3828" @default.
- W3113156128 abstract "Anti-PD1/PDL1 therapy has proven efficacious against many cancers but only reached modest objective response rates against recurrent ovarian cancer. A deeper understanding of the tumor microenvironment (TME) may reveal other immunosuppressive mechanisms that warrant investigation as immunotherapeutic targets for this challenging disease. Matched primary and recurrent tumors from patients with high-grade serous ovarian carcinoma (HGSC) were analyzed by multicolor immunohistochemistry/immunofluorescence for the presence of T cells, B cells, macrophages, and for the expression of immunosuppressive and HLA molecules. Cancer- and immune-related gene expression was assessed by NanoString analysis. Recurrent tumors showed increased infiltration by immune cells, displayed higher expression of PDL1, IDO, and HLA molecules, and contained more stromal tissue. NanoString analysis demonstrated increased expression of gene signatures related to chemokines and T cell functions in recurrent tumors. The ovarian tumors showed high gene expression of LAG3 and HAVCR2 (TIM3) and enhanced levels of TIGIT and CTLA4 in recurrent tumors compared to primary tumors. The majority of HGSC developed into a more inflamed phenotype during progression from primary to recurrent disease, including indications of adaptive immune resistance. This suggests that recurrent tumors may be particularly sensitive to inhibition of adaptive immune resistance mechanisms." @default.
- W3113156128 created "2020-12-21" @default.
- W3113156128 creator A5001378278 @default.
- W3113156128 creator A5018310698 @default.
- W3113156128 creator A5021997701 @default.
- W3113156128 creator A5025825017 @default.
- W3113156128 creator A5026586433 @default.
- W3113156128 creator A5033740747 @default.
- W3113156128 creator A5036265924 @default.
- W3113156128 creator A5037890060 @default.
- W3113156128 creator A5051043977 @default.
- W3113156128 creator A5057467046 @default.
- W3113156128 creator A5057829284 @default.
- W3113156128 creator A5058837420 @default.
- W3113156128 creator A5066165449 @default.
- W3113156128 creator A5071073233 @default.
- W3113156128 creator A5073711705 @default.
- W3113156128 creator A5086241666 @default.
- W3113156128 date "2020-12-18" @default.
- W3113156128 modified "2023-10-01" @default.
- W3113156128 title "Changes in the Tumor Immune Microenvironment during Disease Progression in Patients with Ovarian Cancer" @default.
- W3113156128 cites W1509070276 @default.
- W3113156128 cites W1934094702 @default.
- W3113156128 cites W1944707476 @default.
- W3113156128 cites W1990395010 @default.
- W3113156128 cites W2006983673 @default.
- W3113156128 cites W2009847758 @default.
- W3113156128 cites W2012329749 @default.
- W3113156128 cites W2019090872 @default.
- W3113156128 cites W2019639818 @default.
- W3113156128 cites W2030610701 @default.
- W3113156128 cites W2035335588 @default.
- W3113156128 cites W2036676990 @default.
- W3113156128 cites W2037342985 @default.
- W3113156128 cites W2046911066 @default.
- W3113156128 cites W2059987574 @default.
- W3113156128 cites W2099842815 @default.
- W3113156128 cites W2101653483 @default.
- W3113156128 cites W2105459360 @default.
- W3113156128 cites W2107335150 @default.
- W3113156128 cites W2110660168 @default.
- W3113156128 cites W2114104545 @default.
- W3113156128 cites W2117692326 @default.
- W3113156128 cites W2118548073 @default.
- W3113156128 cites W2125150261 @default.
- W3113156128 cites W2136313650 @default.
- W3113156128 cites W2137074525 @default.
- W3113156128 cites W2147622445 @default.
- W3113156128 cites W2168572010 @default.
- W3113156128 cites W2300386653 @default.
- W3113156128 cites W2312561529 @default.
- W3113156128 cites W2338576144 @default.
- W3113156128 cites W2339963131 @default.
- W3113156128 cites W2527905628 @default.
- W3113156128 cites W2544675721 @default.
- W3113156128 cites W2591765176 @default.
- W3113156128 cites W2724690266 @default.
- W3113156128 cites W2748537281 @default.
- W3113156128 cites W2761383206 @default.
- W3113156128 cites W2765953690 @default.
- W3113156128 cites W2776372829 @default.
- W3113156128 cites W2781525129 @default.
- W3113156128 cites W2785803176 @default.
- W3113156128 cites W2788975052 @default.
- W3113156128 cites W2799575781 @default.
- W3113156128 cites W2800072554 @default.
- W3113156128 cites W2806218907 @default.
- W3113156128 cites W2807649309 @default.
- W3113156128 cites W2890261294 @default.
- W3113156128 cites W2892058240 @default.
- W3113156128 cites W2894424410 @default.
- W3113156128 cites W2895483019 @default.
- W3113156128 cites W2896600825 @default.
- W3113156128 cites W2899760849 @default.
- W3113156128 cites W2903353464 @default.
- W3113156128 cites W2904712055 @default.
- W3113156128 cites W2911940503 @default.
- W3113156128 cites W3006222581 @default.
- W3113156128 cites W3026921722 @default.
- W3113156128 cites W3036427315 @default.
- W3113156128 doi "https://doi.org/10.3390/cancers12123828" @default.
- W3113156128 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7767114" @default.
- W3113156128 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33352957" @default.
- W3113156128 hasPublicationYear "2020" @default.
- W3113156128 type Work @default.
- W3113156128 sameAs 3113156128 @default.
- W3113156128 citedByCount "15" @default.
- W3113156128 countsByYear W31131561282021 @default.
- W3113156128 countsByYear W31131561282022 @default.
- W3113156128 countsByYear W31131561282023 @default.
- W3113156128 crossrefType "journal-article" @default.
- W3113156128 hasAuthorship W3113156128A5001378278 @default.
- W3113156128 hasAuthorship W3113156128A5018310698 @default.
- W3113156128 hasAuthorship W3113156128A5021997701 @default.
- W3113156128 hasAuthorship W3113156128A5025825017 @default.
- W3113156128 hasAuthorship W3113156128A5026586433 @default.
- W3113156128 hasAuthorship W3113156128A5033740747 @default.
- W3113156128 hasAuthorship W3113156128A5036265924 @default.